Helenalin from Centipeda minima ameliorates acute hepatic injury by protecting mitochondria function, activating Nrf2 pathway and inhibiting NF-κB activation

• Published in: Biomedicine & pharmacotherapy 2019-11, Vol.119, p.109435-109435
• Main Authors: Li, Yan, Zeng, Yongmei, Huang, Quanfang, Wen, Shujuan, Wei, Yuanyuan, Chen, Ya, Zhang, Xiaolin, Bai, Facheng, Lu, Zhongpeng, Wei, Jinbin, Lin, Xing
• Format: Article
• Language: English
• Subjects: Acute Disease; Animals; Antioxidants - metabolism; Apoptosis - drug effects; Cytokines - metabolism; Galactosamine; Heme Oxygenase-1 - metabolism; Hepatocytes - drug effects; Hepatocytes - pathology; Inflammation Mediators - metabolism; Lipid Peroxidation - drug effects; Lipopolysaccharides; Liver - drug effects; Liver - injuries; Liver - pathology; Male; Mice, Inbred C57BL; Mitochondria - drug effects; Mitochondria - metabolism; NF-E2-Related Factor 2 - metabolism; NF-kappa B - metabolism; Nitric Oxide - metabolism; Protective Agents - pharmacology; Protective Agents - therapeutic use; Reactive Oxygen Species - metabolism; Sesquiterpenes, Guaiane - pharmacology; Sesquiterpenes, Guaiane - therapeutic use; Signal Transduction - drug effects
• ISSN: 1950-6007
• DOI: 10.1016/j.biopha.2019.109435

Acute liver injury is a life-threatening syndrome that often caused by hepatocyte damage and is characterized by inflammatory and oxidative responses. Helenalin isolated from Centipeda minima (HCM) has been found to have anti-inflammatory and anti-oxidative effects. Here, this study aimed to investigate the effects and underlying mechanisms of HCM on Lipopolysaccharide/D-Galactosamine (LPS/D-GalN)-induced acute liver injury. Mice were intragastrically administered with various dose of HCM for 10 days; 2 h after the final treatment, the mice were injected with 50 μg/kg LPS and 800 mg/kg D-GalN. The histopathological changes, hepatocyte apoptosis, serum cytokines, oxidative stress and inflammatory cytokines were assessed. The results showed that HCM significantly ameliorated the hepatic injury, as evidenced by the attenuation of histopathological changes and the decrease in serum aminotransferase and total bilirubin activities. HCM markedly decreased hepatocyte apoptosis by modulating the mitochondria-dependent pathway, including the increase in the Bcl-2/Bax ratio, the inhibition of caspase-3, -8 and -9, and the inhibition of cytochrome C release. Moreover, HCM strongly alleviated oxidative stress, lipid peroxidation and reactive oxygen species (ROS) generation by activating the Nrf2 signaling pathway. In addition, HCM significantly attenuated inflammatory cytokines including TNF-α, IL6 and IL-1β as well as NO production by inhibiting TLR4 signaling transduction and NF-κB activation. In conclusion, HCM protects hepatocytes from damage induced by LPS/D-GalN, which may contribute to its ability to alleviate hepatocyte apoptosis by protecting the mitochondrial function, inhibit oxidative stress by activating the Nrf2 pathway, and attenuate inflammation by inhibiting NF-κB activation. This study demonstrates that HCM may be developed as a potential agent for the treatment of acute liver failure.